Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
4,698
Views
33
CrossRef citations to date
0
Altmetric
Coronaviruses

Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022

Xinhua Chena Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People’s Republic of China;b Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Xuemei Yana Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People’s Republic of China;b Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Kaiyuan Sunc Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USAView further author information
,
Nan Zhenga Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People’s Republic of China;b Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Ruijia Suna Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People’s Republic of China;b Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Jiaxin Zhoua Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People’s Republic of China;b Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Xiaowei Denga Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People’s Republic of China;b Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Tingyu Zhuanga Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People’s Republic of China;b Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Jun Caia Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People’s Republic of China;b Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Juanjuan Zhanga Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People’s Republic of China;b Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Marco Ajellid Laboratory for Computational Epidemiology and Public Health, Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, IN, USAView further author information
&
Hongjie Yua Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People’s Republic of China;b Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 2800-2807 | Received 21 Jul 2022, Accepted 20 Sep 2022, Published online: 21 Nov 2022

References

  • Commission, S.M.H. COVID-19 Epidemic notification. Vol. 2022 (2022).
  • Commission, S.M.H. The full vaccination coverage is 62 percent for people aged 60 and over in Shanghai. Vol. 2022 (2022).
  • Centre for Health Protection of the Department of Health, H.K. Provisional Data Analysis on COVID-19 Reported Death Cases. Vol. 2022 (2022).
  • McMenamin ME, Nealon J, Lin Y, et al. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study. Lancet Infect Dis. 2022;22:1435–1443.
  • Lauring AS, Tenforde MW, Chappell JD, et al. Clinical severity of, and effectiveness of mRNA vaccines against, COVID-19 from Omicron, Delta, and Alpha SARS-CoV-2 variants in the United States: prospective observational study. Br Med J. 2022;376:e069761.
  • Lewnard JA, Hong VX, Patel MM, et al. Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California. Nat Med. 2022;28:1933–1943.
  • Mesfin Y, Chen D, Bond H, et al. Epidemiology of infections with SARS-CoV-2 Omicron BA.2 variant in Hong Kong, January-March 2022. 2022.2004.2007.22273595 (2022).
  • Commission, T.N.H. Diagnosis and Treatment Protocol for COVID-19 Patient (9th edition). Vol. 2022 (2022).
  • Commission, T.N.H. COVID-19 Prevention and Control Program (8th Edition). Vol. 2022 (2021).
  • Commission, S.M.H. Nucleic acid testing in the whole city. Vol. 2022 (2022).
  • Commission, S.M.H. A new round of nucleic acid testing in the whole Shanghai city. Vol. 2022 (2022).
  • Huang, Z, Xu, S, Liu, J, et al. Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death. BMC Med. 2022;20:400.
  • Sigal A, Milo R, Jassat W. Estimating disease severity of Omicron and Delta SARS-CoV-2 infections. Nat Rev Immunol. 2022;22:267–269.
  • Liu Y, Yu Y, Zhao Y, et al. Reduction in the infection fatality rate of Omicron variant compared with previous variants in South Africa. Int J Infect Dis. 2022;120:146–149.
  • Mesfin Y, Chen D, Bond H, et al. Epidemiology of infections with SARS-CoV-2 Omicron BA.2 variant in Hong Kong, January-March 2022. Emerg Infect Dis. 2022;28:1856–1858.
  • Garske T, Legrand J, Donnelly CA, et al. Assessing the severity of the novel influenza A/H1N1 pandemic. Br Med J. 2009;339:b2840.
  • Zhang X, Zhang W, Chen S. Shanghai’s life-saving efforts against the current Omicron wave of the COVID-19 pandemic. Lancet. 2022;399:2011–2012.
  • Madhi SA, Kwatra G, Myers JE, et al. Population immunity and COVID-19 severity with Omicron variant in South Africa. N Engl J Med. 2022;386:1314–1326.
  • Africa, S.S. South African Community Survey 2016. Vol. 2022 (2016).
  • United Nations. D.o.E.a.S.A. World Population Prospects 2022. Vol. 2022 (2022).
  • Centre for Health Protection of the Department of Health, H.K. Statistics on 5th Wave of COVID-19. Vol. 2022 (2022).
  • Smith DJ, Hakim AJ, Leung GM, et al. COVID-19 mortality and vaccine coverage — Hong Kong special administrative region, China, January 6, 2022–march 21, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:545–548.
  • Cai J, Deng X, Yang J, et al. Modeling transmission of SARS-CoV-2 Omicron in China. Nat Med. 2022;28:1468–1475.
  • Poletti P, Tirani M, Cereda D, et al. Association of age with likelihood of developing symptoms and critical disease among close contacts exposed to patients with confirmed SARS-CoV-2 infection in Italy. JAMA Network Open. 2021;4:e211085.
  • Cohen C, Kleynhans J, von Gottberg A, et al. SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21. Lancet Infect Dis. 2022;22:821–834.
  • Buitrago-Garcia D, Egli-Gany D, Counotte MJ, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 2020;17:e1003346.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.